A new study of previously confidential tobacco industry documents shows that a Philip Morris scientist established close connections with a WHO Collaborating Centre in Thailand called the Chulabhorn Research Institute (CRI). The study is published in this week's PLoS Medicine.

Altria Board of Directors Announces Intention to Pursue the Spin-Off of Philip Morris International and Increases Regular Quarterly Dividend